Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92-463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as Start Printed Page 2227patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-TS-19-001, Identify, Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS).
Date: April 24, 2019.
Time: 11:00 a.m.-5:00 p.m., EDT.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Kimberly Leeks, Ph.D., M.P.H., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F-63, Atlanta, Georgia 30341, Telephone (770) 488-6562, KLeeks@cdc.gov.
The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-01211 Filed 2-5-19; 8:45 am]
BILLING CODE 4163-18-P